The Ubiquitin-proteasome System and Cardiovascular Disease

Overview

Journal Prog Mol Biol Transl Sci

Specialty Molecular Biology

Date 2012 Jun 26

PMID 22727426

Citations 42

Authors

Saul R Powell

Joerg Herrmann

Amir Lerman

Cam Patterson

Xuejun Wang

Affiliations

Soon will be listed here.

Abstract

Over the past decade, the role of the ubiquitin-proteasome system (UPS) has been the subject of numerous studies to elucidate its role in cardiovascular physiology and pathophysiology. There have been many advances in this field including the use of proteomics to achieve a better understanding of how the cardiac proteasome is regulated. Moreover, improved methods for the assessment of UPS function and the development of genetic models to study the role of the UPS have led to the realization that often the function of this system deviates from the norm in many cardiovascular pathologies. Hence, dysfunction has been described in atherosclerosis, familial cardiac proteinopathies, idiopathic dilated cardiomyopathies, and myocardial ischemia. This has led to numerous studies of the ubiquitin protein (E3) ligases and their roles in cardiac physiology and pathophysiology. This has also led to the controversial proposition of treating atherosclerosis, cardiac hypertrophy, and myocardial ischemia with proteasome inhibitors. Furthering our knowledge of this system may help in the development of new UPS-based therapeutic modalities for mitigation of cardiovascular disease.

Citing Articles

The deubiquitinase USP5 prevents accumulation of protein aggregates in cardiomyocytes.

Eibach Y, Kreher S, Poetsch M, Kho A, Gaertner U, Clemen C Sci Adv. 2025; 11(4):eado3852.

PMID: 39841822 PMC: 11753375. DOI: 10.1126/sciadv.ado3852.

USP20 deletion promotes eccentric cardiac remodeling in response to pressure overload and increases mortality.

Jean-Charles P, Roy B, Yu S, Pironti G, Nagi K, Mao L Am J Physiol Heart Circ Physiol. 2024; 327(5):H1257-H1271.

PMID: 39365672 PMC: 11559650. DOI: 10.1152/ajpheart.00329.2024.

Cardiomyocytes Permeabilization and Electrotransfection by Unipolar and Bipolar Asymmetric Electric Field Pulses.

Kulbacka J, Rembialkowska N, Radzeviciute-Valciuke E, Szewczyk A, Novickij V Bioelectricity. 2024; 6(2):91-96.

PMID: 39119571 PMC: 11304875. DOI: 10.1089/bioe.2024.0001.

Crosstalk between ubiquitin ligases and ncRNAs drives cardiovascular disease progression.

You J, Wen Z, Tian J, Lv X, Li R, Li S Front Immunol. 2024; 15:1335519.

PMID: 38515760 PMC: 10954775. DOI: 10.3389/fimmu.2024.1335519.

Casting Light on the Janus-Faced HMG-CoA Reductase Degradation Protein 1: A Comprehensive Review of Its Dualistic Impact on Apoptosis in Various Diseases.

Moghadam R, Daraei A, Haddadi M, Mardi A, Karamali N, Rezaiemanesh A Mol Neurobiol. 2024; 61(9):6842-6863.

PMID: 38356096 DOI: 10.1007/s12035-024-03994-z.

References

Sarikas A, Carrier L, Schenke C, Doll D, Flavigny J, Lindenberg K . Impairment of the ubiquitin-proteasome system by truncated cardiac myosin binding protein C mutants. Cardiovasc Res. 2005; 66(1):33-44. DOI: 10.1016/j.cardiores.2005.01.004. View

van der Heijden J, Oerlemans R, Lems W, Scheper R, Dijkmans B, Jansen G . The proteasome inhibitor bortezomib inhibits the release of NFkappaB-inducible cytokines and induces apoptosis of activated T cells from rheumatoid arthritis patients. Clin Exp Rheumatol. 2009; 27(1):92-8. View

Park Y, Kanekal S, Kehrer J . Oxidative changes in hypoxic rat heart tissue. Am J Physiol. 1991; 260(5 Pt 2):H1395-405. DOI: 10.1152/ajpheart.1991.260.5.H1395. View

Depre C, Wang Q, Yan L, Hedhli N, Peter P, Chen L . Activation of the cardiac proteasome during pressure overload promotes ventricular hypertrophy. Circulation. 2006; 114(17):1821-8. DOI: 10.1161/CIRCULATIONAHA.106.637827. View

Marfella R, DAmico M, Di Filippo C, Baldi A, Siniscalchi M, Sasso F . Increased activity of the ubiquitin-proteasome system in patients with symptomatic carotid disease is associated with enhanced inflammation and may destabilize the atherosclerotic plaque: effects of rosiglitazone treatment. J Am Coll Cardiol. 2006; 47(12):2444-55. DOI: 10.1016/j.jacc.2006.01.073. View

Wilkins B, Dai Y, Bueno O, Parsons S, Xu J, Plank D . Calcineurin/NFAT coupling participates in pathological, but not physiological, cardiac hypertrophy. Circ Res. 2003; 94(1):110-8. DOI: 10.1161/01.RES.0000109415.17511.18. View

Yang Z, Gagarin D, St Laurent 3rd G, Hammell N, Toma I, Hu C . Cardiovascular inflammation and lesion cell apoptosis: a novel connection via the interferon-inducible immunoproteasome. Arterioscler Thromb Vasc Biol. 2009; 29(8):1213-9. PMC: 2762196. DOI: 10.1161/ATVBAHA.109.189407. View

Amici M, Lupidi G, Angeletti M, Fioretti E, Eleuteri A . Peroxynitrite-induced oxidation and its effects on isolated proteasomal systems. Free Radic Biol Med. 2003; 34(8):987-96. DOI: 10.1016/s0891-5849(02)01369-2. View

Marfella R, Di Filippo C, Laieta M, Vestini R, Barbieri M, Sangiulo P . Effects of ubiquitin-proteasome system deregulation on the vascular senescence and atherosclerosis process in elderly patients. J Gerontol A Biol Sci Med Sci. 2008; 63(2):200-3. DOI: 10.1093/gerona/63.2.200. View

10.

Zheng H, Tang M, Zheng Q, Kumarapeli A, Horak K, Tian Z . Doxycycline attenuates protein aggregation in cardiomyocytes and improves survival of a mouse model of cardiac proteinopathy. J Am Coll Cardiol. 2010; 56(17):1418-26. PMC: 2964264. DOI: 10.1016/j.jacc.2010.01.075. View

11.

Gomes M, Lecker S, Jagoe R, Navon A, GOLDBERG A . Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy. Proc Natl Acad Sci U S A. 2001; 98(25):14440-5. PMC: 64700. DOI: 10.1073/pnas.251541198. View

12.

Ogura M, Ayaori M, Terao Y, Hisada T, Iizuka M, Takiguchi S . Proteasomal inhibition promotes ATP-binding cassette transporter A1 (ABCA1) and ABCG1 expression and cholesterol efflux from macrophages in vitro and in vivo. Arterioscler Thromb Vasc Biol. 2011; 31(9):1980-7. DOI: 10.1161/ATVBAHA.111.228478. View

13.

Vieira O, Jurgens G, Borner C, Almeida L, Salvayre R, Negre-Salvayre A . Oxidized LDLs alter the activity of the ubiquitin-proteasome pathway: potential role in oxidized LDL-induced apoptosis. FASEB J. 2000; 14(3):532-42. DOI: 10.1096/fasebj.14.3.532. View

14.

Ishii T, Sakurai T, Usami H, Uchida K . Oxidative modification of proteasome: identification of an oxidation-sensitive subunit in 26 S proteasome. Biochemistry. 2005; 44(42):13893-901. DOI: 10.1021/bi051336u. View

15.

Gilon T, Chomsky O, KULKA R . Degradation signals recognized by the Ubc6p-Ubc7p ubiquitin-conjugating enzyme pair. Mol Cell Biol. 2000; 20(19):7214-9. PMC: 86275. DOI: 10.1128/MCB.20.19.7214-7219.2000. View

16.

Li J, Horak K, Su H, Sanbe A, Robbins J, Wang X . Enhancement of proteasomal function protects against cardiac proteinopathy and ischemia/reperfusion injury in mice. J Clin Invest. 2011; 121(9):3689-700. PMC: 3163952. DOI: 10.1172/JCI45709. View

17.

Richard P, Charron P, Carrier L, Ledeuil C, Cheav T, Pichereau C . Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy. Circulation. 2003; 107(17):2227-32. DOI: 10.1161/01.CIR.0000066323.15244.54. View

18.

Li H, Kedar V, Zhang C, McDonough H, Arya R, Wang D . Atrogin-1/muscle atrophy F-box inhibits calcineurin-dependent cardiac hypertrophy by participating in an SCF ubiquitin ligase complex. J Clin Invest. 2004; 114(8):1058-71. PMC: 522252. DOI: 10.1172/JCI22220. View

19.

Meiners S, Laule M, Rother W, Guenther C, Prauka I, Muschick P . Ubiquitin-proteasome pathway as a new target for the prevention of restenosis. Circulation. 2002; 105(4):483-9. DOI: 10.1161/hc0402.102951. View

20.

Liu J, Chen Q, Huang W, Horak K, Zheng H, Mestril R . Impairment of the ubiquitin-proteasome system in desminopathy mouse hearts. FASEB J. 2005; 20(2):362-4. DOI: 10.1096/fj.05-4869fje. View